Pricing

SalioGen Therapeutics

0 followers

‌

SalioGen Therapeutics is advancing the Exact DNA Integration Technology (EDIT) platform, the only genome engineering technology that is mammal-derived, for use in potentially curative non-viral gene therapy.

Industries

Biotechnology, Education

Headquarters

Cambridge, United States

Employees

51-200

Links

Org chart

Jason F. Cole

CEO & Chairman

Jason F. Cole

Collapse

Will Mcgown

Executive Director, Finance & FP&A

Jill Murray

VP, Human Resources

Joseph J. Higgins

President & Chief Scientific Officer

Jeff Kopacz

SVP of Intellectual Property & Contracts

Joe Senn

SVP & Head of R&D

Jill Murray, PHR

Vice President Human Resources

Oleg Iartchouk

Vice President, Biomarkers And Genomics

William McGowan

Executive Director, Finance And Fp&a

Subhro Guhathakurta

Executive Director, Platform Development & Genetic Engineering

Sujit Jain

Sr Director, CMC Operations

LauraLee Hughes

Director, Corporate Development & Strategy

Quinner Baltazar

Associate Director

Pat Sacco

SVP of Manufacturing, Quality & Operations

Sandeep Nema

SVP, Technical Operations

Teams

+11

Scientific Advisory and Development

14 members

Scientific Research

7 members

Leadership Team

6 members

Similar companies

Jnana Therapeutics

1 follower

Sonoma Biotherapeutics

1 follower

4D Molecular Therapeutics

3 followers

Pivot Bio

2 followers

Quantum-Si

2 followers

Classera

2 followers

EF Education First

13 followers

Cytokinetics

11 followers

brightwheel

10 followers

Artiva Biotherapeutics

1 follower

Neurocrine Biosciences

5 followers

Explore companies